Immunohistochemical staining of the glioma tissue from GBM patients revealed that CD68+ CD206+ M2‐TAMs (mainly referred to as M2‐Mφ) were enriched at the infiltrative margins of glioma (Figure 1G). This evidence concerns the gene CD68 and central nervous system cancer.